Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix to Collect $13.6M From Direct Share Offering

NEW YORK, April 14 (GenomeWeb News) - Acacia Research has found buyers for a  three-million share offering of common stock in its CombiMatrix life sciences unit, the Newport Beach, Calif.-based company said today.


The registered direct offering to a group of undisclosed institutional investors is priced at $5 a share, the company said, discounted against the CombiMatrix closing price of $5.53 on Tuesday. The offering, which will close on Thursday, is expected to raise some $13.6 million for Acacia's Mulkiteo, Wash., subsidiary that is commercializing a microarray technology platform.


The announcement follows CombiMatrix's move from listing on Nasdaq's small-cap market to its big board in March, joining Acacia's other division, Acacia Research/Acacia Technologies, which began trading on the Nasdaq exchange in December 2002.


The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.